Leap Therapeutics
LPTX
LPTX
8 hedge funds and large institutions have $700K invested in Leap Therapeutics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$213K |
2 |
2
Millennium Management
New York
|
$126K |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$84K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$7K |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$0 |
2 |
2
BlackRock
New York
|
$57K |
3 |
3
Morgan Stanley
New York
|
$0 |